Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001641172-25-000372
Filing Date
2025-03-24
Accepted
2025-03-24 17:25:45
Documents
7
Effectiveness Date
2025-03-24

Document Format Files

Seq Description Document Type Size
1 forms-8.htm S-8 75741
2 ex5-1.htm EX-5.1 14969
3 ex10-1.htm EX-10.1 190540
4 ex23-1.htm EX-23.1 4071
5 ex107.htm EX-FILING FEES 13314
6 ex5-1_001.jpg GRAPHIC 12012
7 ex5-1_002.jpg GRAPHIC 19236
  Complete submission text file 0001641172-25-000372.txt   343134
Mailing Address 4851 TAMIAMI TRAIL N, SUITE 200 NAPLES FL 34103
Business Address 4851 TAMIAMI TRAIL N, SUITE 200 NAPLES FL 34103 239-302-1707
Enveric Biosciences, Inc. (Filer) CIK: 0000890821 (see all company filings)

EIN.: 954484725 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-286066 | Film No.: 25765167
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)